nodes	percent_of_prediction	percent_of_DWPC	metapath
Vincristine—Vinca Alkaloids—Vinblastine—testicular cancer	0.29	1	CiPCiCtD
Vincristine—Vinblastine—testicular cancer	0.219	1	CrCtD
Vincristine—muscle cancer—testicular cancer	0.0631	0.38	CtDrD
Vincristine—kidney cancer—testicular cancer	0.0528	0.318	CtDrD
Vincristine—Vindesine—Vinblastine—testicular cancer	0.0514	0.379	CrCrCtD
Vincristine—Vinorelbine—Vinblastine—testicular cancer	0.0514	0.379	CrCrCtD
Vincristine—sarcoma—testicular cancer	0.0503	0.303	CtDrD
Vincristine—Voacamine—Vinblastine—testicular cancer	0.0328	0.242	CrCrCtD
Vincristine—RALBP1—Doxorubicin—testicular cancer	0.00915	0.0621	CbGbCtD
Vincristine—TUBB8—Vinblastine—testicular cancer	0.00855	0.058	CbGbCtD
Vincristine—TUBB2B—Vinblastine—testicular cancer	0.00855	0.058	CbGbCtD
Vincristine—TUBB3—Vinblastine—testicular cancer	0.00855	0.058	CbGbCtD
Vincristine—TUBB2A—Vinblastine—testicular cancer	0.00855	0.058	CbGbCtD
Vincristine—TUBB6—Vinblastine—testicular cancer	0.00855	0.058	CbGbCtD
Vincristine—TUBB4A—Vinblastine—testicular cancer	0.00855	0.058	CbGbCtD
Vincristine—TUBB1—Vinblastine—testicular cancer	0.00715	0.0485	CbGbCtD
Vincristine—TUBB—Vinblastine—testicular cancer	0.00715	0.0485	CbGbCtD
Vincristine—TUBB4B—Vinblastine—testicular cancer	0.00715	0.0485	CbGbCtD
Vincristine—ABCC10—Etoposide—testicular cancer	0.00492	0.0334	CbGbCtD
Vincristine—NR0B1—seminiferous tubule of testis—testicular cancer	0.0041	0.309	CbGeAlD
Vincristine—ABCC1—Dactinomycin—testicular cancer	0.00337	0.0229	CbGbCtD
Vincristine—ABCC10—Doxorubicin—testicular cancer	0.00336	0.0228	CbGbCtD
Vincristine—ABCC10—Methotrexate—testicular cancer	0.00325	0.0221	CbGbCtD
Vincristine—ABCC3—Cisplatin—testicular cancer	0.00315	0.0214	CbGbCtD
Vincristine—ABCC3—Etoposide—testicular cancer	0.0031	0.021	CbGbCtD
Vincristine—ABCB11—Vinblastine—testicular cancer	0.00297	0.0202	CbGbCtD
Vincristine—ABCC1—Epirubicin—testicular cancer	0.00244	0.0166	CbGbCtD
Vincristine—ABCG2—Dactinomycin—testicular cancer	0.00225	0.0153	CbGbCtD
Vincristine—ABCC3—Doxorubicin—testicular cancer	0.00211	0.0143	CbGbCtD
Vincristine—ABCC1—Vinblastine—testicular cancer	0.00211	0.0143	CbGbCtD
Vincristine—ABCC3—Methotrexate—testicular cancer	0.00205	0.0139	CbGbCtD
Vincristine—CYP3A7—Ifosfamide—testicular cancer	0.00197	0.0133	CbGbCtD
Vincristine—CYP3A7-CYP3A51P—Ifosfamide—testicular cancer	0.00197	0.0133	CbGbCtD
Vincristine—ABCC1—Etoposide—testicular cancer	0.0019	0.0129	CbGbCtD
Vincristine—ABCB11—Doxorubicin—testicular cancer	0.00183	0.0124	CbGbCtD
Vincristine—ABCC2—Carboplatin—testicular cancer	0.00168	0.0114	CbGbCtD
Vincristine—ABCC2—Vinblastine—testicular cancer	0.00156	0.0106	CbGbCtD
Vincristine—ABCG2—Carboplatin—testicular cancer	0.00152	0.0103	CbGbCtD
Vincristine—CYP3A5—Ifosfamide—testicular cancer	0.00147	0.01	CbGbCtD
Vincristine—ABCC2—Cisplatin—testicular cancer	0.00143	0.00972	CbGbCtD
Vincristine—ABCC2—Etoposide—testicular cancer	0.00141	0.00955	CbGbCtD
Vincristine—ABCC1—Doxorubicin—testicular cancer	0.0013	0.0088	CbGbCtD
Vincristine—ABCG2—Cisplatin—testicular cancer	0.00129	0.00879	CbGbCtD
Vincristine—ABCG2—Etoposide—testicular cancer	0.00127	0.00863	CbGbCtD
Vincristine—ABCC1—Methotrexate—testicular cancer	0.00126	0.00852	CbGbCtD
Vincristine—ABCC2—Doxorubicin—testicular cancer	0.00096	0.00651	CbGbCtD
Vincristine—ABCC2—Methotrexate—testicular cancer	0.00093	0.00631	CbGbCtD
Vincristine—ABCG2—Doxorubicin—testicular cancer	0.000868	0.00589	CbGbCtD
Vincristine—ABCG2—Methotrexate—testicular cancer	0.000841	0.0057	CbGbCtD
Vincristine—ABCB1—Dactinomycin—testicular cancer	0.000813	0.00552	CbGbCtD
Vincristine—CYP3A5—Etoposide—testicular cancer	0.000705	0.00478	CbGbCtD
Vincristine—CYP3A4—Ifosfamide—testicular cancer	0.000575	0.0039	CbGbCtD
Vincristine—ABCB1—Vinblastine—testicular cancer	0.000509	0.00346	CbGbCtD
Vincristine—ABCB1—Cisplatin—testicular cancer	0.000467	0.00317	CbGbCtD
Vincristine—ABCB1—Etoposide—testicular cancer	0.000459	0.00311	CbGbCtD
Vincristine—NR0B1—gonad—testicular cancer	0.000348	0.0262	CbGeAlD
Vincristine—ABCB1—Doxorubicin—testicular cancer	0.000313	0.00212	CbGbCtD
Vincristine—CYP3A4—Vinblastine—testicular cancer	0.000305	0.00207	CbGbCtD
Vincristine—ABCB1—Methotrexate—testicular cancer	0.000303	0.00206	CbGbCtD
Vincristine—NR0B1—female gonad—testicular cancer	0.000283	0.0213	CbGeAlD
Vincristine—CYP3A4—Etoposide—testicular cancer	0.000275	0.00187	CbGbCtD
Vincristine—TUBB8—testis—testicular cancer	0.00027	0.0203	CbGeAlD
Vincristine—TUBA4A—seminal vesicle—testicular cancer	0.000268	0.0202	CbGeAlD
Vincristine—RALBP1—seminal vesicle—testicular cancer	0.000253	0.0191	CbGeAlD
Vincristine—NR0B1—testis—testicular cancer	0.000251	0.0189	CbGeAlD
Vincristine—TUBB4A—embryo—testicular cancer	0.000229	0.0173	CbGeAlD
Vincristine—TUBB2B—seminal vesicle—testicular cancer	0.000208	0.0157	CbGeAlD
Vincristine—TUBB—seminal vesicle—testicular cancer	0.000197	0.0148	CbGeAlD
Vincristine—TUBB2A—seminal vesicle—testicular cancer	0.000195	0.0147	CbGeAlD
Vincristine—TUBA4A—gonad—testicular cancer	0.000194	0.0146	CbGeAlD
Vincristine—TUBB6—seminal vesicle—testicular cancer	0.000193	0.0145	CbGeAlD
Vincristine—CYP3A4—Doxorubicin—testicular cancer	0.000187	0.00127	CbGbCtD
Vincristine—TUBB3—testis—testicular cancer	0.000184	0.0139	CbGeAlD
Vincristine—TUBB1—testis—testicular cancer	0.00018	0.0136	CbGeAlD
Vincristine—TUBB4B—embryo—testicular cancer	0.000178	0.0135	CbGeAlD
Vincristine—ABCC10—seminal vesicle—testicular cancer	0.000169	0.0127	CbGeAlD
Vincristine—TUBB4B—seminal vesicle—testicular cancer	0.000168	0.0126	CbGeAlD
Vincristine—TUBA4A—female gonad—testicular cancer	0.000157	0.0119	CbGeAlD
Vincristine—TUBB4A—gonad—testicular cancer	0.000155	0.0117	CbGeAlD
Vincristine—SLC22A3—embryo—testicular cancer	0.000154	0.0116	CbGeAlD
Vincristine—TUBB2B—gonad—testicular cancer	0.00015	0.0113	CbGeAlD
Vincristine—RALBP1—female gonad—testicular cancer	0.000148	0.0112	CbGeAlD
Vincristine—SLC22A3—seminal vesicle—testicular cancer	0.000144	0.0109	CbGeAlD
Vincristine—TUBA4A—testis—testicular cancer	0.00014	0.0105	CbGeAlD
Vincristine—TUBB6—gonad—testicular cancer	0.000139	0.0105	CbGeAlD
Vincristine—ABCB11—testis—testicular cancer	0.000139	0.0105	CbGeAlD
Vincristine—RALBP1—testis—testicular cancer	0.000132	0.00993	CbGeAlD
Vincristine—TUBB4A—female gonad—testicular cancer	0.000126	0.00951	CbGeAlD
Vincristine—ABCC10—gonad—testicular cancer	0.000122	0.0092	CbGeAlD
Vincristine—TUBB2B—female gonad—testicular cancer	0.000122	0.0092	CbGeAlD
Vincristine—TUBB4B—gonad—testicular cancer	0.000121	0.00913	CbGeAlD
Vincristine—ABCC1—seminal vesicle—testicular cancer	0.000119	0.009	CbGeAlD
Vincristine—TUBB—female gonad—testicular cancer	0.000115	0.0087	CbGeAlD
Vincristine—TUBB2A—female gonad—testicular cancer	0.000115	0.00866	CbGeAlD
Vincristine—TUBB6—female gonad—testicular cancer	0.000113	0.00854	CbGeAlD
Vincristine—TUBB4A—testis—testicular cancer	0.000112	0.00844	CbGeAlD
Vincristine—TUBB2B—testis—testicular cancer	0.000108	0.00816	CbGeAlD
Vincristine—SLC22A3—gonad—testicular cancer	0.000104	0.00787	CbGeAlD
Vincristine—TUBB—testis—testicular cancer	0.000102	0.00772	CbGeAlD
Vincristine—TUBB2A—testis—testicular cancer	0.000102	0.00768	CbGeAlD
Vincristine—TUBA4A—lymph node—testicular cancer	0.000101	0.00763	CbGeAlD
Vincristine—TUBB6—testis—testicular cancer	0.0001	0.00757	CbGeAlD
Vincristine—ABCC3—female gonad—testicular cancer	9.96e-05	0.00751	CbGeAlD
Vincristine—ABCC10—female gonad—testicular cancer	9.91e-05	0.00748	CbGeAlD
Vincristine—ABCG2—seminal vesicle—testicular cancer	9.89e-05	0.00745	CbGeAlD
Vincristine—TUBB4B—female gonad—testicular cancer	9.84e-05	0.00742	CbGeAlD
Vincristine—RALBP1—lymph node—testicular cancer	9.54e-05	0.00719	CbGeAlD
Vincristine—ABCC3—testis—testicular cancer	8.84e-05	0.00666	CbGeAlD
Vincristine—ABCC10—testis—testicular cancer	8.79e-05	0.00663	CbGeAlD
Vincristine—TUBB4B—testis—testicular cancer	8.73e-05	0.00658	CbGeAlD
Vincristine—SLC22A3—female gonad—testicular cancer	8.48e-05	0.0064	CbGeAlD
Vincristine—TUBB4A—lymph node—testicular cancer	8.11e-05	0.00612	CbGeAlD
Vincristine—TUBB2B—lymph node—testicular cancer	7.84e-05	0.00591	CbGeAlD
Vincristine—SLC22A3—testis—testicular cancer	7.52e-05	0.00567	CbGeAlD
Vincristine—TUBB—lymph node—testicular cancer	7.42e-05	0.00559	CbGeAlD
Vincristine—TUBB2A—lymph node—testicular cancer	7.38e-05	0.00557	CbGeAlD
Vincristine—TUBB6—lymph node—testicular cancer	7.28e-05	0.00549	CbGeAlD
Vincristine—ABCC2—testis—testicular cancer	7.06e-05	0.00532	CbGeAlD
Vincristine—ABCC1—female gonad—testicular cancer	7.01e-05	0.00529	CbGeAlD
Vincristine—ABCC3—lymph node—testicular cancer	6.4e-05	0.00483	CbGeAlD
Vincristine—ABCC10—lymph node—testicular cancer	6.37e-05	0.00481	CbGeAlD
Vincristine—TUBB4B—lymph node—testicular cancer	6.33e-05	0.00477	CbGeAlD
Vincristine—ABCC1—testis—testicular cancer	6.22e-05	0.00469	CbGeAlD
Vincristine—ABCG2—female gonad—testicular cancer	5.81e-05	0.00438	CbGeAlD
Vincristine—SLC22A3—lymph node—testicular cancer	5.45e-05	0.00411	CbGeAlD
Vincristine—CYP3A5—female gonad—testicular cancer	5.39e-05	0.00406	CbGeAlD
Vincristine—ABCB1—embryo—testicular cancer	5.19e-05	0.00391	CbGeAlD
Vincristine—ABCG2—testis—testicular cancer	5.15e-05	0.00388	CbGeAlD
Vincristine—ABCC2—lymph node—testicular cancer	5.12e-05	0.00386	CbGeAlD
Vincristine—ABCB1—seminal vesicle—testicular cancer	4.87e-05	0.00368	CbGeAlD
Vincristine—ABCC1—lymph node—testicular cancer	4.51e-05	0.0034	CbGeAlD
Vincristine—ABCG2—lymph node—testicular cancer	3.73e-05	0.00281	CbGeAlD
Vincristine—ABCB1—gonad—testicular cancer	3.52e-05	0.00266	CbGeAlD
Vincristine—ABCB1—female gonad—testicular cancer	2.86e-05	0.00216	CbGeAlD
Vincristine—ABCB1—testis—testicular cancer	2.54e-05	0.00191	CbGeAlD
Vincristine—Vomiting—Vinblastine—testicular cancer	2.24e-05	0.00079	CcSEcCtD
Vincristine—Vertigo—Etoposide—testicular cancer	2.21e-05	0.000779	CcSEcCtD
Vincristine—Decreased appetite—Ifosfamide—testicular cancer	2.21e-05	0.000779	CcSEcCtD
Vincristine—Headache—Vinblastine—testicular cancer	2.21e-05	0.000778	CcSEcCtD
Vincristine—Leukopenia—Etoposide—testicular cancer	2.2e-05	0.000776	CcSEcCtD
Vincristine—Gastrointestinal disorder—Ifosfamide—testicular cancer	2.2e-05	0.000774	CcSEcCtD
Vincristine—Abdominal pain—Dactinomycin—testicular cancer	2.19e-05	0.000773	CcSEcCtD
Vincristine—Body temperature increased—Dactinomycin—testicular cancer	2.19e-05	0.000773	CcSEcCtD
Vincristine—Fatigue—Ifosfamide—testicular cancer	2.19e-05	0.000773	CcSEcCtD
Vincristine—Oedema—Cisplatin—testicular cancer	2.19e-05	0.000773	CcSEcCtD
Vincristine—Anaphylactic shock—Cisplatin—testicular cancer	2.19e-05	0.000773	CcSEcCtD
Vincristine—Hypersensitivity—Bleomycin—testicular cancer	2.19e-05	0.000773	CcSEcCtD
Vincristine—Cardiac arrest—Epirubicin—testicular cancer	2.18e-05	0.000768	CcSEcCtD
Vincristine—Infection—Cisplatin—testicular cancer	2.18e-05	0.000768	CcSEcCtD
Vincristine—Pain—Ifosfamide—testicular cancer	2.17e-05	0.000766	CcSEcCtD
Vincristine—Constipation—Ifosfamide—testicular cancer	2.17e-05	0.000766	CcSEcCtD
Vincristine—Ataxia—Epirubicin—testicular cancer	2.15e-05	0.000759	CcSEcCtD
Vincristine—Nervous system disorder—Cisplatin—testicular cancer	2.15e-05	0.000758	CcSEcCtD
Vincristine—Thrombocytopenia—Cisplatin—testicular cancer	2.15e-05	0.000757	CcSEcCtD
Vincristine—Asthenia—Bleomycin—testicular cancer	2.13e-05	0.000752	CcSEcCtD
Vincristine—Convulsion—Etoposide—testicular cancer	2.13e-05	0.000752	CcSEcCtD
Vincristine—Dehydration—Epirubicin—testicular cancer	2.13e-05	0.000751	CcSEcCtD
Vincristine—Hyponatraemia—Doxorubicin—testicular cancer	2.13e-05	0.00075	CcSEcCtD
Vincristine—Hypertension—Etoposide—testicular cancer	2.12e-05	0.000749	CcSEcCtD
Vincristine—Pain in extremity—Doxorubicin—testicular cancer	2.12e-05	0.000747	CcSEcCtD
Vincristine—Hyperhidrosis—Cisplatin—testicular cancer	2.12e-05	0.000747	CcSEcCtD
Vincristine—Nausea—Vinblastine—testicular cancer	2.09e-05	0.000738	CcSEcCtD
Vincristine—Anorexia—Cisplatin—testicular cancer	2.09e-05	0.000737	CcSEcCtD
Vincristine—Gastrointestinal pain—Ifosfamide—testicular cancer	2.08e-05	0.000733	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Epirubicin—testicular cancer	2.06e-05	0.000727	CcSEcCtD
Vincristine—Hypotension—Cisplatin—testicular cancer	2.05e-05	0.000722	CcSEcCtD
Vincristine—Hypersensitivity—Dactinomycin—testicular cancer	2.04e-05	0.000721	CcSEcCtD
Vincristine—Muscular weakness—Epirubicin—testicular cancer	2.02e-05	0.000712	CcSEcCtD
Vincristine—Cardiac arrest—Doxorubicin—testicular cancer	2.02e-05	0.00071	CcSEcCtD
Vincristine—Abdominal pain—Ifosfamide—testicular cancer	2.01e-05	0.000709	CcSEcCtD
Vincristine—Body temperature increased—Ifosfamide—testicular cancer	2.01e-05	0.000709	CcSEcCtD
Vincristine—Pancytopenia—Methotrexate—testicular cancer	2.01e-05	0.000708	CcSEcCtD
Vincristine—Anaphylactic shock—Etoposide—testicular cancer	2.01e-05	0.000708	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Cisplatin—testicular cancer	2e-05	0.000704	CcSEcCtD
Vincristine—Infection—Etoposide—testicular cancer	2e-05	0.000703	CcSEcCtD
Vincristine—Ataxia—Doxorubicin—testicular cancer	1.99e-05	0.000702	CcSEcCtD
Vincristine—Asthenia—Dactinomycin—testicular cancer	1.99e-05	0.000702	CcSEcCtD
Vincristine—Neutropenia—Methotrexate—testicular cancer	1.98e-05	0.000697	CcSEcCtD
Vincristine—Dysuria—Methotrexate—testicular cancer	1.98e-05	0.000697	CcSEcCtD
Vincristine—Dehydration—Doxorubicin—testicular cancer	1.97e-05	0.000695	CcSEcCtD
Vincristine—Paraesthesia—Cisplatin—testicular cancer	1.97e-05	0.000694	CcSEcCtD
Vincristine—Thrombocytopenia—Etoposide—testicular cancer	1.97e-05	0.000693	CcSEcCtD
Vincristine—Erectile dysfunction—Methotrexate—testicular cancer	1.95e-05	0.000687	CcSEcCtD
Vincristine—Hyperhidrosis—Etoposide—testicular cancer	1.94e-05	0.000684	CcSEcCtD
Vincristine—Photosensitivity reaction—Methotrexate—testicular cancer	1.93e-05	0.000681	CcSEcCtD
Vincristine—Anorexia—Etoposide—testicular cancer	1.91e-05	0.000675	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Doxorubicin—testicular cancer	1.91e-05	0.000673	CcSEcCtD
Vincristine—Decreased appetite—Cisplatin—testicular cancer	1.91e-05	0.000672	CcSEcCtD
Vincristine—Diarrhoea—Dactinomycin—testicular cancer	1.9e-05	0.000669	CcSEcCtD
Vincristine—Pneumonia—Methotrexate—testicular cancer	1.9e-05	0.000669	CcSEcCtD
Vincristine—Gastrointestinal disorder—Cisplatin—testicular cancer	1.89e-05	0.000667	CcSEcCtD
Vincristine—Vomiting—Bleomycin—testicular cancer	1.89e-05	0.000667	CcSEcCtD
Vincristine—Depression—Methotrexate—testicular cancer	1.88e-05	0.000663	CcSEcCtD
Vincristine—Pancytopenia—Epirubicin—testicular cancer	1.88e-05	0.000663	CcSEcCtD
Vincristine—Hypotension—Etoposide—testicular cancer	1.88e-05	0.000661	CcSEcCtD
Vincristine—Rash—Bleomycin—testicular cancer	1.88e-05	0.000661	CcSEcCtD
Vincristine—Pain—Cisplatin—testicular cancer	1.87e-05	0.000661	CcSEcCtD
Vincristine—Dermatitis—Bleomycin—testicular cancer	1.87e-05	0.000661	CcSEcCtD
Vincristine—Hypersensitivity—Ifosfamide—testicular cancer	1.87e-05	0.00066	CcSEcCtD
Vincristine—Muscular weakness—Doxorubicin—testicular cancer	1.87e-05	0.000659	CcSEcCtD
Vincristine—Neutropenia—Epirubicin—testicular cancer	1.85e-05	0.000653	CcSEcCtD
Vincristine—Dysuria—Epirubicin—testicular cancer	1.85e-05	0.000653	CcSEcCtD
Vincristine—ABCB1—lymph node—testicular cancer	1.84e-05	0.00139	CbGeAlD
Vincristine—Stomatitis—Methotrexate—testicular cancer	1.84e-05	0.000648	CcSEcCtD
Vincristine—Asthenia—Ifosfamide—testicular cancer	1.82e-05	0.000643	CcSEcCtD
Vincristine—Sweating—Methotrexate—testicular cancer	1.81e-05	0.000637	CcSEcCtD
Vincristine—Photosensitivity reaction—Epirubicin—testicular cancer	1.81e-05	0.000637	CcSEcCtD
Vincristine—Paraesthesia—Etoposide—testicular cancer	1.8e-05	0.000636	CcSEcCtD
Vincristine—Weight decreased—Epirubicin—testicular cancer	1.79e-05	0.000631	CcSEcCtD
Vincristine—Pneumonia—Epirubicin—testicular cancer	1.78e-05	0.000626	CcSEcCtD
Vincristine—Nausea—Bleomycin—testicular cancer	1.77e-05	0.000623	CcSEcCtD
Vincristine—Vomiting—Dactinomycin—testicular cancer	1.76e-05	0.000622	CcSEcCtD
Vincristine—Rash—Dactinomycin—testicular cancer	1.75e-05	0.000617	CcSEcCtD
Vincristine—Decreased appetite—Etoposide—testicular cancer	1.75e-05	0.000615	CcSEcCtD
Vincristine—Diarrhoea—Ifosfamide—testicular cancer	1.74e-05	0.000613	CcSEcCtD
Vincristine—Pancytopenia—Doxorubicin—testicular cancer	1.74e-05	0.000613	CcSEcCtD
Vincristine—Gastrointestinal disorder—Etoposide—testicular cancer	1.73e-05	0.000611	CcSEcCtD
Vincristine—Body temperature increased—Cisplatin—testicular cancer	1.73e-05	0.000611	CcSEcCtD
Vincristine—Fatigue—Etoposide—testicular cancer	1.73e-05	0.00061	CcSEcCtD
Vincristine—Neuropathy peripheral—Epirubicin—testicular cancer	1.73e-05	0.00061	CcSEcCtD
Vincristine—Stomatitis—Epirubicin—testicular cancer	1.72e-05	0.000606	CcSEcCtD
Vincristine—Constipation—Etoposide—testicular cancer	1.72e-05	0.000605	CcSEcCtD
Vincristine—Pain—Etoposide—testicular cancer	1.72e-05	0.000605	CcSEcCtD
Vincristine—Dysuria—Doxorubicin—testicular cancer	1.71e-05	0.000604	CcSEcCtD
Vincristine—Neutropenia—Doxorubicin—testicular cancer	1.71e-05	0.000604	CcSEcCtD
Vincristine—Sweating—Epirubicin—testicular cancer	1.69e-05	0.000596	CcSEcCtD
Vincristine—Dizziness—Ifosfamide—testicular cancer	1.68e-05	0.000593	CcSEcCtD
Vincristine—Urinary tract disorder—Methotrexate—testicular cancer	1.67e-05	0.000589	CcSEcCtD
Vincristine—Photosensitivity reaction—Doxorubicin—testicular cancer	1.67e-05	0.000589	CcSEcCtD
Vincristine—Urethral disorder—Methotrexate—testicular cancer	1.66e-05	0.000585	CcSEcCtD
Vincristine—Weight decreased—Doxorubicin—testicular cancer	1.66e-05	0.000584	CcSEcCtD
Vincristine—Nausea—Dactinomycin—testicular cancer	1.65e-05	0.000581	CcSEcCtD
Vincristine—Pneumonia—Doxorubicin—testicular cancer	1.64e-05	0.000579	CcSEcCtD
Vincristine—Gastrointestinal pain—Etoposide—testicular cancer	1.64e-05	0.000579	CcSEcCtD
Vincristine—Vomiting—Ifosfamide—testicular cancer	1.62e-05	0.00057	CcSEcCtD
Vincristine—Hypersensitivity—Cisplatin—testicular cancer	1.62e-05	0.000569	CcSEcCtD
Vincristine—Rash—Ifosfamide—testicular cancer	1.6e-05	0.000565	CcSEcCtD
Vincristine—Dermatitis—Ifosfamide—testicular cancer	1.6e-05	0.000565	CcSEcCtD
Vincristine—Neuropathy peripheral—Doxorubicin—testicular cancer	1.6e-05	0.000564	CcSEcCtD
Vincristine—Stomatitis—Doxorubicin—testicular cancer	1.59e-05	0.000561	CcSEcCtD
Vincristine—Abdominal pain—Etoposide—testicular cancer	1.59e-05	0.00056	CcSEcCtD
Vincristine—Body temperature increased—Etoposide—testicular cancer	1.59e-05	0.00056	CcSEcCtD
Vincristine—Hypoaesthesia—Epirubicin—testicular cancer	1.58e-05	0.000556	CcSEcCtD
Vincristine—Asthenia—Cisplatin—testicular cancer	1.57e-05	0.000554	CcSEcCtD
Vincristine—Cardiac disorder—Methotrexate—testicular cancer	1.57e-05	0.000554	CcSEcCtD
Vincristine—Sweating—Doxorubicin—testicular cancer	1.57e-05	0.000552	CcSEcCtD
Vincristine—Urinary tract disorder—Epirubicin—testicular cancer	1.56e-05	0.000552	CcSEcCtD
Vincristine—Connective tissue disorder—Epirubicin—testicular cancer	1.56e-05	0.000549	CcSEcCtD
Vincristine—Urethral disorder—Epirubicin—testicular cancer	1.55e-05	0.000548	CcSEcCtD
Vincristine—Angiopathy—Methotrexate—testicular cancer	1.54e-05	0.000541	CcSEcCtD
Vincristine—Mediastinal disorder—Methotrexate—testicular cancer	1.53e-05	0.000538	CcSEcCtD
Vincristine—Nausea—Ifosfamide—testicular cancer	1.51e-05	0.000532	CcSEcCtD
Vincristine—Diarrhoea—Cisplatin—testicular cancer	1.5e-05	0.000529	CcSEcCtD
Vincristine—Alopecia—Methotrexate—testicular cancer	1.5e-05	0.000527	CcSEcCtD
Vincristine—Mental disorder—Methotrexate—testicular cancer	1.48e-05	0.000523	CcSEcCtD
Vincristine—Hypersensitivity—Etoposide—testicular cancer	1.48e-05	0.000522	CcSEcCtD
Vincristine—Cardiac disorder—Epirubicin—testicular cancer	1.47e-05	0.000518	CcSEcCtD
Vincristine—Hypoaesthesia—Doxorubicin—testicular cancer	1.46e-05	0.000514	CcSEcCtD
Vincristine—Urinary tract disorder—Doxorubicin—testicular cancer	1.45e-05	0.00051	CcSEcCtD
Vincristine—Asthenia—Etoposide—testicular cancer	1.44e-05	0.000508	CcSEcCtD
Vincristine—Connective tissue disorder—Doxorubicin—testicular cancer	1.44e-05	0.000508	CcSEcCtD
Vincristine—Angiopathy—Epirubicin—testicular cancer	1.44e-05	0.000507	CcSEcCtD
Vincristine—Urethral disorder—Doxorubicin—testicular cancer	1.44e-05	0.000507	CcSEcCtD
Vincristine—Mediastinal disorder—Epirubicin—testicular cancer	1.43e-05	0.000503	CcSEcCtD
Vincristine—Back pain—Methotrexate—testicular cancer	1.43e-05	0.000503	CcSEcCtD
Vincristine—Alopecia—Epirubicin—testicular cancer	1.4e-05	0.000494	CcSEcCtD
Vincristine—Vomiting—Cisplatin—testicular cancer	1.39e-05	0.000491	CcSEcCtD
Vincristine—Mental disorder—Epirubicin—testicular cancer	1.39e-05	0.000489	CcSEcCtD
Vincristine—Rash—Cisplatin—testicular cancer	1.38e-05	0.000487	CcSEcCtD
Vincristine—Dermatitis—Cisplatin—testicular cancer	1.38e-05	0.000487	CcSEcCtD
Vincristine—Diarrhoea—Etoposide—testicular cancer	1.37e-05	0.000484	CcSEcCtD
Vincristine—Anaemia—Methotrexate—testicular cancer	1.36e-05	0.00048	CcSEcCtD
Vincristine—Cardiac disorder—Doxorubicin—testicular cancer	1.36e-05	0.00048	CcSEcCtD
Vincristine—Back pain—Epirubicin—testicular cancer	1.33e-05	0.00047	CcSEcCtD
Vincristine—Angiopathy—Doxorubicin—testicular cancer	1.33e-05	0.000469	CcSEcCtD
Vincristine—Dizziness—Etoposide—testicular cancer	1.33e-05	0.000468	CcSEcCtD
Vincristine—Vertigo—Methotrexate—testicular cancer	1.32e-05	0.000467	CcSEcCtD
Vincristine—Mediastinal disorder—Doxorubicin—testicular cancer	1.32e-05	0.000466	CcSEcCtD
Vincristine—Leukopenia—Methotrexate—testicular cancer	1.32e-05	0.000465	CcSEcCtD
Vincristine—Nausea—Cisplatin—testicular cancer	1.3e-05	0.000459	CcSEcCtD
Vincristine—Alopecia—Doxorubicin—testicular cancer	1.3e-05	0.000457	CcSEcCtD
Vincristine—Mental disorder—Doxorubicin—testicular cancer	1.28e-05	0.000453	CcSEcCtD
Vincristine—Convulsion—Methotrexate—testicular cancer	1.28e-05	0.00045	CcSEcCtD
Vincristine—Vomiting—Etoposide—testicular cancer	1.28e-05	0.00045	CcSEcCtD
Vincristine—Anaemia—Epirubicin—testicular cancer	1.27e-05	0.000449	CcSEcCtD
Vincristine—Agitation—Epirubicin—testicular cancer	1.27e-05	0.000447	CcSEcCtD
Vincristine—Rash—Etoposide—testicular cancer	1.27e-05	0.000446	CcSEcCtD
Vincristine—Dermatitis—Etoposide—testicular cancer	1.27e-05	0.000446	CcSEcCtD
Vincristine—Headache—Etoposide—testicular cancer	1.26e-05	0.000443	CcSEcCtD
Vincristine—Myalgia—Methotrexate—testicular cancer	1.25e-05	0.000442	CcSEcCtD
Vincristine—Vertigo—Epirubicin—testicular cancer	1.24e-05	0.000437	CcSEcCtD
Vincristine—Leukopenia—Epirubicin—testicular cancer	1.23e-05	0.000435	CcSEcCtD
Vincristine—Back pain—Doxorubicin—testicular cancer	1.23e-05	0.000435	CcSEcCtD
Vincristine—Anaphylactic shock—Methotrexate—testicular cancer	1.2e-05	0.000424	CcSEcCtD
Vincristine—Convulsion—Epirubicin—testicular cancer	1.2e-05	0.000421	CcSEcCtD
Vincristine—Infection—Methotrexate—testicular cancer	1.2e-05	0.000421	CcSEcCtD
Vincristine—Nausea—Etoposide—testicular cancer	1.19e-05	0.00042	CcSEcCtD
Vincristine—Hypertension—Epirubicin—testicular cancer	1.19e-05	0.00042	CcSEcCtD
Vincristine—Nervous system disorder—Methotrexate—testicular cancer	1.18e-05	0.000416	CcSEcCtD
Vincristine—Anaemia—Doxorubicin—testicular cancer	1.18e-05	0.000416	CcSEcCtD
Vincristine—Thrombocytopenia—Methotrexate—testicular cancer	1.18e-05	0.000415	CcSEcCtD
Vincristine—Myalgia—Epirubicin—testicular cancer	1.17e-05	0.000414	CcSEcCtD
Vincristine—Agitation—Doxorubicin—testicular cancer	1.17e-05	0.000413	CcSEcCtD
Vincristine—Hyperhidrosis—Methotrexate—testicular cancer	1.16e-05	0.00041	CcSEcCtD
Vincristine—Vertigo—Doxorubicin—testicular cancer	1.15e-05	0.000404	CcSEcCtD
Vincristine—Anorexia—Methotrexate—testicular cancer	1.15e-05	0.000404	CcSEcCtD
Vincristine—Leukopenia—Doxorubicin—testicular cancer	1.14e-05	0.000403	CcSEcCtD
Vincristine—Anaphylactic shock—Epirubicin—testicular cancer	1.13e-05	0.000397	CcSEcCtD
Vincristine—Oedema—Epirubicin—testicular cancer	1.13e-05	0.000397	CcSEcCtD
Vincristine—Hypotension—Methotrexate—testicular cancer	1.12e-05	0.000396	CcSEcCtD
Vincristine—Infection—Epirubicin—testicular cancer	1.12e-05	0.000394	CcSEcCtD
Vincristine—Convulsion—Doxorubicin—testicular cancer	1.11e-05	0.00039	CcSEcCtD
Vincristine—Nervous system disorder—Epirubicin—testicular cancer	1.1e-05	0.000389	CcSEcCtD
Vincristine—Thrombocytopenia—Epirubicin—testicular cancer	1.1e-05	0.000389	CcSEcCtD
Vincristine—Hypertension—Doxorubicin—testicular cancer	1.1e-05	0.000388	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Methotrexate—testicular cancer	1.1e-05	0.000386	CcSEcCtD
Vincristine—Hyperhidrosis—Epirubicin—testicular cancer	1.09e-05	0.000384	CcSEcCtD
Vincristine—Insomnia—Methotrexate—testicular cancer	1.09e-05	0.000384	CcSEcCtD
Vincristine—Myalgia—Doxorubicin—testicular cancer	1.09e-05	0.000383	CcSEcCtD
Vincristine—Paraesthesia—Methotrexate—testicular cancer	1.08e-05	0.000381	CcSEcCtD
Vincristine—Anorexia—Epirubicin—testicular cancer	1.07e-05	0.000378	CcSEcCtD
Vincristine—Hypotension—Epirubicin—testicular cancer	1.05e-05	0.000371	CcSEcCtD
Vincristine—Decreased appetite—Methotrexate—testicular cancer	1.05e-05	0.000369	CcSEcCtD
Vincristine—Anaphylactic shock—Doxorubicin—testicular cancer	1.04e-05	0.000367	CcSEcCtD
Vincristine—Oedema—Doxorubicin—testicular cancer	1.04e-05	0.000367	CcSEcCtD
Vincristine—Gastrointestinal disorder—Methotrexate—testicular cancer	1.04e-05	0.000366	CcSEcCtD
Vincristine—Fatigue—Methotrexate—testicular cancer	1.04e-05	0.000366	CcSEcCtD
Vincristine—Infection—Doxorubicin—testicular cancer	1.03e-05	0.000365	CcSEcCtD
Vincristine—Pain—Methotrexate—testicular cancer	1.03e-05	0.000363	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Epirubicin—testicular cancer	1.03e-05	0.000362	CcSEcCtD
Vincristine—Nervous system disorder—Doxorubicin—testicular cancer	1.02e-05	0.00036	CcSEcCtD
Vincristine—Thrombocytopenia—Doxorubicin—testicular cancer	1.02e-05	0.000359	CcSEcCtD
Vincristine—Insomnia—Epirubicin—testicular cancer	1.02e-05	0.000359	CcSEcCtD
Vincristine—Paraesthesia—Epirubicin—testicular cancer	1.01e-05	0.000356	CcSEcCtD
Vincristine—Hyperhidrosis—Doxorubicin—testicular cancer	1.01e-05	0.000355	CcSEcCtD
Vincristine—Anorexia—Doxorubicin—testicular cancer	9.93e-06	0.00035	CcSEcCtD
Vincristine—Gastrointestinal pain—Methotrexate—testicular cancer	9.84e-06	0.000347	CcSEcCtD
Vincristine—Decreased appetite—Epirubicin—testicular cancer	9.79e-06	0.000345	CcSEcCtD
Vincristine—Hypotension—Doxorubicin—testicular cancer	9.73e-06	0.000343	CcSEcCtD
Vincristine—Gastrointestinal disorder—Epirubicin—testicular cancer	9.72e-06	0.000343	CcSEcCtD
Vincristine—Fatigue—Epirubicin—testicular cancer	9.71e-06	0.000342	CcSEcCtD
Vincristine—Constipation—Epirubicin—testicular cancer	9.63e-06	0.000339	CcSEcCtD
Vincristine—Pain—Epirubicin—testicular cancer	9.63e-06	0.000339	CcSEcCtD
Vincristine—Body temperature increased—Methotrexate—testicular cancer	9.51e-06	0.000335	CcSEcCtD
Vincristine—Abdominal pain—Methotrexate—testicular cancer	9.51e-06	0.000335	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Doxorubicin—testicular cancer	9.49e-06	0.000335	CcSEcCtD
Vincristine—Insomnia—Doxorubicin—testicular cancer	9.42e-06	0.000332	CcSEcCtD
Vincristine—Paraesthesia—Doxorubicin—testicular cancer	9.35e-06	0.00033	CcSEcCtD
Vincristine—Gastrointestinal pain—Epirubicin—testicular cancer	9.21e-06	0.000324	CcSEcCtD
Vincristine—Decreased appetite—Doxorubicin—testicular cancer	9.06e-06	0.000319	CcSEcCtD
Vincristine—Gastrointestinal disorder—Doxorubicin—testicular cancer	8.99e-06	0.000317	CcSEcCtD
Vincristine—Fatigue—Doxorubicin—testicular cancer	8.98e-06	0.000317	CcSEcCtD
Vincristine—Pain—Doxorubicin—testicular cancer	8.91e-06	0.000314	CcSEcCtD
Vincristine—Constipation—Doxorubicin—testicular cancer	8.91e-06	0.000314	CcSEcCtD
Vincristine—Abdominal pain—Epirubicin—testicular cancer	8.9e-06	0.000314	CcSEcCtD
Vincristine—Body temperature increased—Epirubicin—testicular cancer	8.9e-06	0.000314	CcSEcCtD
Vincristine—Hypersensitivity—Methotrexate—testicular cancer	8.86e-06	0.000312	CcSEcCtD
Vincristine—Asthenia—Methotrexate—testicular cancer	8.63e-06	0.000304	CcSEcCtD
Vincristine—Gastrointestinal pain—Doxorubicin—testicular cancer	8.52e-06	0.0003	CcSEcCtD
Vincristine—Hypersensitivity—Epirubicin—testicular cancer	8.29e-06	0.000292	CcSEcCtD
Vincristine—Abdominal pain—Doxorubicin—testicular cancer	8.23e-06	0.00029	CcSEcCtD
Vincristine—Body temperature increased—Doxorubicin—testicular cancer	8.23e-06	0.00029	CcSEcCtD
Vincristine—Diarrhoea—Methotrexate—testicular cancer	8.23e-06	0.00029	CcSEcCtD
Vincristine—Asthenia—Epirubicin—testicular cancer	8.08e-06	0.000285	CcSEcCtD
Vincristine—Dizziness—Methotrexate—testicular cancer	7.95e-06	0.00028	CcSEcCtD
Vincristine—Diarrhoea—Epirubicin—testicular cancer	7.7e-06	0.000272	CcSEcCtD
Vincristine—Hypersensitivity—Doxorubicin—testicular cancer	7.67e-06	0.000271	CcSEcCtD
Vincristine—Vomiting—Methotrexate—testicular cancer	7.65e-06	0.00027	CcSEcCtD
Vincristine—Rash—Methotrexate—testicular cancer	7.58e-06	0.000267	CcSEcCtD
Vincristine—Dermatitis—Methotrexate—testicular cancer	7.58e-06	0.000267	CcSEcCtD
Vincristine—Headache—Methotrexate—testicular cancer	7.54e-06	0.000266	CcSEcCtD
Vincristine—Asthenia—Doxorubicin—testicular cancer	7.47e-06	0.000263	CcSEcCtD
Vincristine—Dizziness—Epirubicin—testicular cancer	7.44e-06	0.000262	CcSEcCtD
Vincristine—Vomiting—Epirubicin—testicular cancer	7.16e-06	0.000252	CcSEcCtD
Vincristine—Nausea—Methotrexate—testicular cancer	7.15e-06	0.000252	CcSEcCtD
Vincristine—Diarrhoea—Doxorubicin—testicular cancer	7.13e-06	0.000251	CcSEcCtD
Vincristine—Rash—Epirubicin—testicular cancer	7.1e-06	0.00025	CcSEcCtD
Vincristine—Dermatitis—Epirubicin—testicular cancer	7.09e-06	0.00025	CcSEcCtD
Vincristine—Headache—Epirubicin—testicular cancer	7.05e-06	0.000249	CcSEcCtD
Vincristine—Dizziness—Doxorubicin—testicular cancer	6.89e-06	0.000243	CcSEcCtD
Vincristine—Nausea—Epirubicin—testicular cancer	6.69e-06	0.000236	CcSEcCtD
Vincristine—Vomiting—Doxorubicin—testicular cancer	6.62e-06	0.000233	CcSEcCtD
Vincristine—Rash—Doxorubicin—testicular cancer	6.57e-06	0.000232	CcSEcCtD
Vincristine—Dermatitis—Doxorubicin—testicular cancer	6.56e-06	0.000231	CcSEcCtD
Vincristine—Headache—Doxorubicin—testicular cancer	6.53e-06	0.00023	CcSEcCtD
Vincristine—Nausea—Doxorubicin—testicular cancer	6.19e-06	0.000218	CcSEcCtD
